Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-049673

VP, Clinical Trial Operations sold 29,800 shares at $21.14 ($629,927)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-13 Sale : show line 1 in the form −29,800 $21.14 $629,927 106,135 D
Open-market sales · 29,800 sh · avg $21.14 · $629,927
Loading xslF345X05/doc4.xml…